Izrael -
hebrejski -
Ministry of Health
אקסלון 1.5 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Izrael -
hebrejski -
Ministry of Health
אקסלון 3 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Izrael -
hebrejski -
Ministry of Health
אקסלון 4.5 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Izrael -
hebrejski -
Ministry of Health
אקסלון 6 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Izrael -
hebrejski -
Ministry of Health
אקסלון מדבקה 5
novartis pharma services ag - rivastigmine 4.6 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.
Izrael -
hebrejski -
Ministry of Health
אקסלון מדבקה 10
novartis pharma services ag - rivastigmine 9.5 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.
Izrael -
hebrejski -
Ministry of Health
ריוואסטיגמין אינובמד 1.5 מ"ג
inovamed ltd - rivastigmine as hydrogen tartrate 1.5 mg - capsules - rivastigmine - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Izrael -
hebrejski -
Ministry of Health
אלציגמין 1.5
rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine
Izrael -
hebrejski -
Ministry of Health
אלציגמין 3
rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine
Izrael -
hebrejski -
Ministry of Health
אלציגמין 4.5
rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine